Abildgaard, L., Ellebaek, E., Gustafsson, G., Abrahamsson, J., Hovi, L., Jonmundsson, G., . . . Hasle, H. (2006). Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature. Ann Hematol, 85(5), 275-280.
Abla, O., Egeler, R. M., & Weitzman, S. (2010). Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev, 36(4), 354-359.
Abramson, D. H., Greenfield, D. S., & Ellsworth, R. M. (1992). Bilateral retinoblastoma. Correlations between age at diagnosis and time course for new intraocular tumors. Ophthalmic Paediatr Genet, 13(1), 1-7.
Abzug, M. J. (2009). Vaccination in the immunocompromised child: a probe of immune reconstitution. Pediatr Infect Dis J, 28(3), 233-236.
Akuttveileder i pediatri [e-bok]. (2013). (3 utg.). Tromsø: Norsk barnelegeforening. Hentet fra http://www.helsebiblioteket.no/retningslinjer/akuttveileder-i-pediatri/forside
Andolina, J. R., Neudorf, S. M., & Corey, S. J. (2012). How I treat childhood CML. Blood, 119(8), 1821-1830.
Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., . . . Armand, P. (2015). PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med, 372(4), 311-319. https://doi.org/10.1056/NEJMoa1411087
Aronson, D. C., Schnater, J. M., Staalman, C. R., Weverling, G. J., Plaschkes, J., Perilongo, G., . . . Vos, A. (2005). Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol, 23(6), 1245-1252.
Australian Technical Advisory Group on Immunisation (ATAGI). (2018). Australian Immunisation Handbook. Canberra: Australian Government Department of Health. Hentet fra https://immunisationhandbook.health.gov.au/
Bate, J., Borrow, R., Chisholm, J., Clark, S., Dixon, E., Faust, S. N., . . . Gray, J. C. (2019). 13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Oct 5, [epub ahead of print]. https://doi.org/10.1093/cid/ciz965
Beckwith, J. B. (1998). Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet, 79(4), 268-273.
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., . . . Bernstein, M. (2015). Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol, 33(20), 2279-2287. https://doi.org/10.1200/jco.2014.60.0734
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (BIOMEDE). (2014-). [pågående studie]. (NCT02233049). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02233049
Bisogno, G., & Bergeron, C. (2005). Soft tissue sarcoma. I: P. A. Voûte, A. Barrett, M. C. G. Stevens , & H. N. Carson (red.), Cancer in children: clinical management (s. 255-279). Oxford: Oxford University Press.
Bosetti, C., Bertuccio, P., Chatenoud, L., Negri, E., Levi, F., & La, V. C. (2010). Childhood cancer mortality in Europe, 1970-2007. Eur J Cancer, 46(2), 384-394.
Bouffet, E., Jakacki, R., Goldman, S., Hargrave, D., Hawkins, C., Shroff, M., . . . Baruchel, S. (2012). Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol, 30(12), 1358-1363.
Bouffet, E., Tabori, U., Huang, A., & Bartels, U. (2009). Ependymoma: lessons from the past, prospects for the future. Childs Nerv Syst, 25(11), 1383-1384; author reply 1385. https://doi.org/10.1007/s00381-009-0915-6
Braunstein, S., Raleigh, D., Bindra, R., Mueller, S., & Haas-Kogan, D. (2017). Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol, 134(3), 541-549. https://doi.org/10.1007/s11060-017-2393-0
Cage, T. A., Clark, A. J., Aranda, D., Gupta, N., Sun, P. P., Parsa, A. T., & Auguste, K. I. (2013). A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. J Neurosurg Pediatr, 11(6), 673-681. https://doi.org/10.3171/2013.2.peds12345
Cancer in children: clinical management. (2005). (5 utg.). Oxford: Oxford University Press.
Caniza, M. A., Hunger, S. P., Schrauder, A., Valsecchi, M. G., Pui, C. H., & Masera, G. (2012). The controversy of varicella vaccination in children with acute lymphoblastic leukemia. Pediatr Blood Cancer, 58(1), 12-16. https://doi.org/10.1002/pbc.22759
Carreras, E., Dufour, C., Mohty, M., & Kröger, N. (red.). (2019). The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Cham, Switzerland: Springer. Hentet fra https://pubmed.ncbi.nlm.nih.gov/32091673/
Ceppi, F., Weitzman, S., Woessmann, W., Davies, K., Lassaletta, A., Reismuller, B., . . . Alexander, S. (2016). Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study. American journal of hematology, 91(5), 486-491. https://doi.org/10.1002/ajh.24329
Childhood cancer in the Nordic countries. (2008). Linköping: Nordic society of Pediatric Haematology and Oncology.
Cohen, B. H., Zeltzer, P. M., Boyett, J. M., Geyer, J. R., Allen, J. C., Finlay, J. L., . . . et al. (1995). Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial. J Clin Oncol, 13(7), 1687-1696. https://doi.org/10.1200/jco.1995.13.7.1687
Cohen, K. J., Pollack, I. F., Zhou, T., Buxton, A., Holmes, E. J., Burger, P. C., . . . Heideman, R. L. (2011). Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol, 13(3), 317-323. https://doi.org/10.1093/neuonc/noq191
Cohn, S. L., Pearson, A. D., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., . . . Matthay, K. K. (2009). The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol, 27(2), 289-297.
Cook, R. L., O'Dwyer, N. J., Parker, H. M., Donges, C. E., Cheng, H. L., Steinbeck, K. S., . . . O'Connor, H. T. (2017). Iron Deficiency Anemia, Not Iron Deficiency, Is Associated with Reduced Attention in Healthy Young Women. Nutrients, 9(11), 1216. https://doi.org/10.3390/nu9111216
Cordonnier, C., Labopin, M., Chesnel, V., Ribaud, P., De La Camara, R., Martino, R., . . . Ljungman, P. (2009). Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 48(10), 1392-1401. https://doi.org/10.1086/598324
Creutzig, U., Reinhardt, D., Diekamp, S., Dworzak, M., Stary, J., & Zimmermann, M. (2005). AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia, 19(8), 1355-1360.
Dickerman, J. D. (2007). The late effects of childhood cancer therapy. Pediatrics, 119(3), 554-568.
Dimaras, H., Kimani, K., Dimba, E. A., Gronsdahl, P., White, A., Chan, H. S., & Gallie, B. L. (2012). Retinoblastoma. Lancet, 379(9824), 1436-1446. https://doi.org/10.1016/s0140-6736(11)61137-9
Dorffel, W., Ruhl, U., Luders, H., Claviez, A., Albrecht, M., Bokkerink, J., . . . Schellong, G. (2013). Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol, 31(12), 1562-1568.
Due-Tønnessen, B. J., Helseth, E., Scheie, D., Skullerud, K., Aamodt, G., & Lundar, T. (2002). Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0-19 years): report of 110 consecutive cases. Pediatr Neurosurg, 37(2), 71-80. https://doi.org/10.1159/000065108
Due-Tønnessen, B. J., Lundar, T., Egge, A., & Scheie, D. (2013). Neurosurgical treatment of low-grade cerebellar astrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. J Neurosurg Pediatr, 11(3), 245-249.
Ellison, D. W., Kocak, M., Figarella-Branger, D., Felice, G., Catherine, G., Pietsch, T., . . . Grundy, R. G. (2011). Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. Journal of negative results in biomedicine, 10, 7. https://doi.org/10.1186/1477-5751-10-7
Esposito, S., Cecinati, V., Brescia, L., & Principi, N. (2010). Vaccinations in children with cancer. Vaccine, 28(19), 3278-3284.
Foreldrekontakttjenesten. (2013). [nettside]. Oslo: Barnekreftforeningen. Hentet 8. aug. 2013, fra http://www.barnekreftforeningen.no/for-medlemmer/foreldre-m/
Forestier, E., & Schmiegelow, K. (2006). The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol, 28(8), 486-495.
Fossey, M., Li, H., Afzal, S., Carret, A. S., Eisenstat, D. D., Fleming, A., . . . Lafay-Cousin, L. (2017). Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. J Neurooncol, 132(1), 155-162. https://doi.org/10.1007/s11060-016-2353-0
Fouladi, M., Hunt, D. L., Pollack, I. F., Dueckers, G., Burger, P. C., Becker, L. E., . . . Finlay, J. L. (2003). Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer, 98(6), 1243-1252. https://doi.org/10.1002/cncr.11637
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature, 323(6089), 643-646.
Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., . . . Levis, A. (2007). Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol, 25(24), 3746-3752. https://doi.org/10.1200/jco.2007.11.6525
Gatta, G., Botta, L., Rossi, S., Aareleid, T., Bielska-Lasota, M., Clavel, J., . . . Peris-Bonet, R. (2014). Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. The Lancet. Oncology, 15(1), 35-47. https://doi.org/10.1016/s1470-2045(13)70548-5
Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., & Terenziani, M. (2005). Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol, 23(16), 3742-3751.
Gatta, G., Zigon, G., Capocaccia, R., Coebergh, J. W., Desandes, E., Kaatsch, P., . . . Stiller, C. A. (2009). Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer, 45(6), 992-1005.
Gaze, M. N., Chang, Y. C., Flux, G. D., Mairs, R. J., Saran, F. H., & Meller, S. T. (2005). Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma. Cancer biotherapy & radiopharmaceuticals, 20(2), 195-199. https://doi.org/10.1089/cbr.2005.20.195
Generell veileder i pediatri [e-bok]. (2012). (2 utg.). Tromsø: Norsk barnelegeforening. Hentet fra http://www.helsebiblioteket.no/retningslinjer/pediatri/forside
Gianno F, A. M., Ferretti E, Massimino M, Arcella A, Giangaspero F. (2018). Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers. Glioma, (1), 117-124.
Gibson, B. E., Todd, A., Roberts, I., Pamphilon, D., Rodeck, C., Bolton-Maggs, P., . . . Turner, G. (2004). Transfusion guidelines for neonates and older children. Br J Haematol, 124(4), 433-453.
Gielen, G. H., Gessi, M., Buttarelli, F. R., Baldi, C., Hammes, J., zur Muehlen, A., . . . Pietsch, T. (2015). Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity. Brain pathology (Zurich, Switzerland), 25(4), 409-417. https://doi.org/10.1111/bpa.12210
Gnekow, A. K., Kandels, D., van Tilburg, C., Azizi, A. A., Opocher, E., Stokland, T., . . . Witt, O. (2019). SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma. Klinische Padiatrie, 231(3), 107-135. https://doi.org/10.1055/a-0889-8256
Gnekow, A. K., Packer, R., & Kortmann, R. D. (2004). Astrocytic tumors, low-grade. I: D. V. Walker, G. Perilongo, J. A. G. Punt, & R. Taylor (red.), Brain and spinal tumors of childhood (s. 245-276). London: Arnold.
Gobel, U., Calaminus, G., Engert, J., Kaatsch, P., Gadner, H., Bokkerink, J. P., . . . Harms, D. (1998). Teratomas in infancy and childhood. Med Pediatr Oncol, 31(1), 8-15.
Gobel, U., Schneider, D. T., Calaminus, G., Haas, R. J., Schmidt, P., & Harms, D. (2000). Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol, 11(3), 263-271.
Goldman, S., Smith, L., Anderson, J. R., Perkins, S., Harrison, L., Geyer, M. B., . . . Cairo, M. S. (2013). Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Leukemia, 27(5), 1174-1177.
Gregersen, P. A., Urbak, S. F., Funding, M., Overgaard, J., Jensen, U. B., & Alsner, J. (2016). Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications. Acta Oncol, 55(4), 412-417. https://doi.org/10.3109/0284186X.2015.1099732
Grill, J., Le Deley, M. C., Gambarelli, D., Raquin, M. A., Couanet, D., Pierre-Kahn, A., . . . Kalifa, C. (2001). Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol, 19(5), 1288-1296. https://doi.org/10.1200/jco.2001.19.5.1288
Grundy, R. G., Wilne, S. A., Weston, C. L., Robinson, K., Lashford, L. S., Ironside, J., . . . Machin, D. (2007). Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. The Lancet. Oncology, 8(8), 696-705. https://doi.org/10.1016/s1470-2045(07)70208-5
Gunnes, M. W., Lie, R. T., Bjørge, T., Ghaderi, S., Ruud, E., Syse, A., & Moster, D. (2016). Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study. British journal of cancer, 114(3), 348-356. https://doi.org/10.1038/bjc.2015.455
Gupta, A., & Dwivedi, T. (2017). A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016. Journal of neurosciences in rural practice, 8(4), 629-641. https://doi.org/10.4103/jnrp.jnrp_168_17
Gustafsson, B., Hellebostad, M., Ifversen, M., Sander, B., & Hasle, H. (2011). Acute respiratory failure in 3 children with juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol, 33(8), e363-e367.
Gustafsson, G., Schmiegelow, K., Forestier, E., Clausen, N., Glomstein, A., Jonmundsson, G., . . . Saarinen-Pihkala, U. M. (2000). Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia, 14(12), 2267-2275.
Hagberg-van't Hooft, I. (2005). Cognitive rehabilitation in children with acquired brain injuries [doktorgrad]. Stockholm: Karolinska institutet, Department of Women's and Children's Health. Hentet fra http://publications.ki.se/xmlui/bitstream/handle/10616/39503/thesis.pdf?sequence=1
Hamre, H., Zeller, B., Kanellopoulos, A., Kiserud, C. E., Aakhus, S., Lund, M. B., . . . Ruud, E. (2012). High Prevalence of Chronic Fatigue in Adult Long-Term Survivors of Acute Lymphoblastic Leukemia and Lymphoma During Childhood and Adolescence. Journal of Adolescent and Young Adult Oncology, 2(1), 2-9. https://doi.org/10.1089/jayao.2012.0015
Hargrave, D. (2009). Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Br J Neurosurg, 23(4), 351-363.
Hasle, H., Abrahamsson, J., Forestier, E., Ha, S. Y., Heldrup, J., Jahnukainen, K., . . . Zeller, B. (2012). Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004. Blood, 120(5), 978-984.
Helsedirektoratet. (2013). Beslutningsprosesser for begrensning av livsforlengende behandling hos alvorlige syke og døende (rev. utg.). (IS-2091). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/veiledere/beslutningsprosesser-ved-begrensning-av-livsforlengende-behandling
Helsedirektoratet. (4. mai 2017). Palliasjon til barn og unge: nasjonal faglig retningslinje. [nettdokument]. Oslo: Helsedirektoratet. Hentet 5. mai 2020, fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-til-barn-og-unge
Helsedirektoratet. (2018). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av sarkom (3. utg.). (IS-2697). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/sarkomer-handlingsprogram
Helsedirektoratet. (2019). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne lymfomer (IS-2747). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/lymfekreft-handlingsprogram
Henter, J. I., Elinder, G., Soder, O., & Ost, A. (1991). Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand, 80(4), 428-435.
Henter, J. I., Horne, A., Arico, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., . . . Janka, G. (2007). HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 48(2), 124-131.
Hodgson, S. V., & Maher, E. R. (1999). A practical guide to human cancer genetics (2 utg.). Cambridge: Cambridge University Press.
Hwang, E. I., Jakacki, R. I., Fisher, M. J., Kilburn, L. B., Horn, M., Vezina, G., . . . Packer, R. J. (2013). Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer, 60(5), 776-782.
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma (SIOP-EP-II). (2015-2026). [pågående studie]. (NCT02265770). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02265770
Jakacki, R. I., Cohen, K. J., Buxton, A., Krailo, M. D., Burger, P. C., Rosenblum, M. K., . . . Pollack, I. F. (2016). Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol, 18(10), 1442-1450. https://doi.org/10.1093/neuonc/now038
Janka, G. E. (2007). Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr, 166(2), 95-109.
Japp, A. S., Klein-Hitpass, L., Denkhaus, D., & Pietsch, T. (2017). OTX2 Defines a Subgroup of Atypical Teratoid Rhabdoid Tumors With Close Relationship to Choroid Plexus Tumors. Journal of neuropathology and experimental neurology, 76(1), 32-38. https://doi.org/10.1093/jnen/nlw101
Johann, P. D., Erkek, S., Zapatka, M., Kerl, K., Buchhalter, I., Hovestadt, V., . . . Kool, M. (2016). Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell, 29(3), 379-393. https://doi.org/10.1016/j.ccell.2016.02.001
Kager, L., Zoubek, A., Potschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., . . . Bielack, S. S. (2003). Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol, 21(10), 2011-2018.
Kaste, S. C., Dome, J. S., Babyn, P. S., Graf, N. M., Grundy, P., Godzinski, J., . . . Jenkinson, H. (2008). Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol, 38(1), 2-17.
Khatua, S., Ramaswamy, V., & Bouffet, E. (2017). Current therapy and the evolving molecular landscape of paediatric ependymoma. Eur J Cancer, 70, 34-41. https://doi.org/10.1016/j.ejca.2016.10.013
Kim, J. W., Abramson, D. H., & Dunkel, I. J. (2007). Current management strategies for intraocular retinoblastoma. Drugs, 67(15), 2173-2185.
Kleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., . . . Fraumeni, J. F., Jr. (2005). Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol, 23(10), 2272-2279. https://doi.org/10.1200/JCO.2005.05.054
Kleinerman, R. A., Yu, C. L., Little, M. P., Li, Y., Abramson, D., Seddon, J., & Tucker, M. A. (2012). Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol, 30(9), 950-957. https://doi.org/10.1200/JCO.2011.37.0239
Kohno, S., Kitajima, S., Sasaki, N., & Takahashi, C. (2016). Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies. World journal of stem cells, 8(4), 170-184. https://doi.org/10.4252/wjsc.v8.i4.170
Kolmannskog, S., Flaegstad, T., Helgestad, J., Hellebostad, M., Zeller, B., & Glomstein, A. (2007). Akutt lymfatisk leukemi hos barn i Norge 1992-2000. Tidsskr Nor Laegeforen, 127(11), 1493-1495.
Kreftoverlevere: ny kunnskap og nye muligheter i et langtidsperspektiv. (2009). Oslo: Gyldendal akademisk.
Krepischi, A. C., Capelli, L. P., Silva, A. G., de Araujo, E. S., Pearson, P. L., Heck, B., . . . Rosenberg, C. (2014). Large germline copy number variations as predisposing factor in childhood neoplasms. Future oncology (London, England), 10(9), 1627-1633. https://doi.org/10.2217/fon.14.41
Kaatsch, P., Steliarova-Foucher, E., Crocetti, E., Magnani, C., Spix, C., & Zambon, P. (2006). Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer, 42(13), 1961-1971.
Larsen, I. K. (red.). (2018). Cancer in Norway 2018: Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2018/cin2018.pdf
Late effects of childhood cancer. (2004). London: Arnold.
Levisohn, L., Cronin-Golomb, A., & Schmahmann, J. D. (2000). Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain, 123 ( Pt 5), 1041-1050.
Lie, S. O., Abrahamsson, J., Clausen, N., Forestier, E., Hasle, H., Hovi, L., . . . Gustafsson, G. (2005). Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Leukemia, 19(12), 2090-2100.
Ljungman, P., Cordonnier, C., Einsele, H., Englund, J., Machado, C. M., Storek, J., & Small, T. (2009). Vaccination of hematopoietic cell transplant recipients. Bone marrow transplantation, 44(8), 521-526. https://doi.org/10.1038/bmt.2009.263
Lote, K., Hatlevoll, R., Bakke, S. J., Due-Tønnessen, B., Helseth, E., Lundar, T., . . . Skullerud, K. (2000). Langtids overlevelse etter kirurgi og strålebehandling av hjernesvulster i barnealder. Tidsskr Nor Laegeforen, 120(10), 1142-1145.
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., . . . Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica, 114(2), 97-109. https://doi.org/10.1007/s00401-007-0243-4
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., . . . Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta neuropathologica, 131(6), 803-820. https://doi.org/10.1007/s00401-016-1545-1
Lu, V. M., Welby, J. P., Mahajan, A., Laack, N. N., & Daniels, D. J. (2019). Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis. Childs Nerv Syst, 35(5), 739-746. https://doi.org/10.1007/s00381-019-04118-y
Lundar, T., Due-Tonnessen, B. J., Scheie, D., & Brandal, P. (2014). Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients. Childs Nerv Syst, 30(12), 2083-2088. https://doi.org/10.1007/s00381-014-2491-7
Lundar, T., Due-Tønnessen, B. J., Egge, A., Scheie, D., Brandal, P., Stensvold, E., & Due-Tønnessen, P. (2014). Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients. J Neurosurg Pediatr, 14(6), 598-603. https://doi.org/10.3171/2014.9.Peds1462
Mann, G., Attarbaschi, A., Schrappe, M., De, L. P., Peters, C., Hann, I., . . . Pieters, R. (2010). Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. Blood, 116(15), 2644-2650.
Mann, J. R., Raafat, F., Robinson, K., Imeson, J., Gornall, P., Sokal, M., . . . Oakhill, A. (2000). The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol, 18(22), 3809-3818.
Marin, M., Leung, J., & Gershon, A. A. (2019). Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review. Pediatrics, 144(3). https://doi.org/10.1542/peds.2019-1305
Massimino, M., Gandola, L., Giangaspero, F., Sandri, A., Valagussa, P., Perilongo, G., . . . Madon, E. (2004). Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys, 58(5), 1336-1345. https://doi.org/10.1016/j.ijrobp.2003.08.030
Massimino, M., Gandola, L., Spreafico, F., Luksch, R., Collini, P., Giangaspero, F., . . . Fossati-Bellani, F. (2006). Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Int J Radiat Oncol Biol Phys, 64(4), 1031-1037.
Mauz-Korholz, C., Gorde-Grosjean, S., Hasenclever, D., Shankar, A., Dorffel, W., Wallace, W. H., . . . Landman-Parker, J. (2007). Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer, 110(1), 179-185.
Mauz-Korholz, C., Hasenclever, D., Dorffel, W., Ruschke, K., Pelz, T., Voigt, A., . . . Korholz, D. (2010). Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol, 28(23), 3680-3686. https://doi.org/10.1200/jco.2009.26.9381
Medikamentell kreftbehandling: cytostatikaboken. (2009). (7 utg.). Oslo: Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo.
Meinhardt, A., Burkhardt, B., Zimmermann, M., Borkhardt, A., Kontny, U., Klingebiel, T., . . . Reiter, A. (2010). Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J Clin Oncol, 28(19), 3115-3121.
Merchant, T. E., Li, C., Xiong, X., Kun, L. E., Boop, F. A., & Sanford, R. A. (2009). Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. The Lancet. Oncology, 10(3), 258-266. https://doi.org/10.1016/s1470-2045(08)70342-5
Minard-Colin, V., Brugieres, L., Reiter, A., Cairo, M. S., Gross, T. G., Woessmann, W., . . . Patte, C. (2015). Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead. J Clin Oncol, 33(27), 2963-2974. https://doi.org/10.1200/jco.2014.59.5827
Monclair, T., Brodeur, G. M., Ambros, P. F., Brisse, H. J., Cecchetto, G., Holmes, K., . . . Pearson, A. D. (2009). The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol, 27(2), 298-303. https://doi.org/10.1200/jco.2008.16.6876
Moskowitz, C. H., Walewski, J., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., . . . Sweetenham, J. (2018). Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse. Blood, 132(25), 2639-2642. https://doi.org/10.1182/blood-2018-07-861641
Mulhern, R. K. (2003). Cognitive sequelae. Brain Injury, 17(Suppl 1), 5.
Mulhern, R. K., & Butler, R. W. (2004). Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Radiol, 7(1), 1-14.
Muller, H. L. (2010). Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Rev Neurother, 10(4), 515-524.
Murphree, A. L. (2005). Intraocular retinoblastoma: the case for a new group classification. Ophthalamic Oncology, Ophthalmology Clinics of North America, 18(1), 41-53.
Nasjonal helseplan (2007-2010). (2006). (Særtrykk av St.prp. nr. 1 (2006-2007) kapittel 6). Oslo: Helse- og omsorgsdepartemenetet. Hentet fra http://www.regjeringen.no/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf
Nasjonalt kvalitetsregister for barnekreft. (2015). Årsrapport 2014. Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2015/aarsrapport_2014_barnekreft.pdf
Nasjonalt kvalitetsregister for barnekreft. (2018). Årsrapport 2018: resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for barnekreft. Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2019/arsrapport-2018-barnekreft.pdf
Nordiske retningslinjer for retinoblastom. (2016). Oslo: Nordisk retinoblastom gruppe.
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., . . . Robison, L. L. (2006). Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 355(15), 1572-1582.
Offit, K. (1998). Clinical cancer genetics: risk counselling and management. New York: Wiley-Liss.
Olsen, D. R., Bruland, O. S., Frykholm, G., & Norderhaug, I. N. (2007). Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol, 83(2), 123-132.
Oppfølging av kreftoverlevere med særlig fokus på seneffekter: innstilling fra en arbeidsgruppe nedsatt av Helsedirektoratet. (2010). Oslo: Arbeidsgruppen. Hentet fra https://www.legeforeningen.no/contentassets/67b4a31a81c1491d933ecfee02332269/seneffekter-av-kreftbehandling-hoeringsvedlegg.pdf
Packer, R. J., Pfister, S., Bouffet, E., Avery, R., Bandopadhayay, P., Bornhorst, M., . . . Kieran, M. (2017). Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol, 19(6), 750-761. https://doi.org/10.1093/neuonc/now209
Pajtler, K. W., Mack, S. C., Ramaswamy, V., Smith, C. A., Witt, H., Smith, A., . . . Taylor, M. D. (2017). The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta neuropathologica, 133(1), 5-12. https://doi.org/10.1007/s00401-016-1643-0
Pajtler, K. W., Witt, H., Sill, M., Jones, D. T., Hovestadt, V., Kratochwil, F., . . . Pfister, S. M. (2015). Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell, 27(5), 728-743. https://doi.org/10.1016/j.ccell.2015.04.002
Paulussen, M., Kovar, H., & Jürgens, H. (2005). Ewing sarcoma and peripheral primitive neuroectodermal tumour. I: P. A. Voûte, A. Barrett, M. C. G. Stevens, & H. N. Carson (red.), Cancer in children: clinical management (5 utg., s. 301-320). Oxford: Oxford University Press.
Pejavar, S., Polley, M. Y., Rosenberg-Wohl, S., Chennupati, S., Prados, M. D., Berger, M. S., . . . Haas-Kogan, D. (2012). Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol, 106(2), 367-375. https://doi.org/10.1007/s11060-011-0671-9
Perilongo, G. (2005). Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma. J Neurooncol, 75(3), 301-307.
Perilongo, G., Maibach, R., Shafford, E., Brugieres, L., Brock, P., Morland, B., . . . Czauderna, P. (2009). Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med, 361(17), 1662-1670. https://doi.org/10.1056/NEJMoa0810613
Perilongo, G., Shafford, E., Maibach, R., Aronson, D., Brugieres, L., Brock, P., . . . Plaschkes, J. (2004). Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer, 40(3), 411-421.
Pieters, R., Schrappe, M., De, L. P., Hann, I., De, R. G., Felice, M., . . . Valsecchi, M. G. (2007). A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet, 370(9583), 240-250.
Pinto, N. R., Applebaum, M. A., Volchenboum, S. L., Matthay, K. K., London, W. B., Ambros, P. F., . . . Cohn, S. L. (2015). Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol, 33(27), 3008-3017. https://doi.org/10.1200/jco.2014.59.4648
Principles and practice of pediatric oncology. (2006). (5 utg.). Philadelphia: Lippincott Williams & Wilkins.
Pritchard-Jones, K., & Pritchard, J. (2004). Success of clinical trials in childhood Wilms' tumour around the world. Lancet, 364(9444), 1468-1470.
Pritchard, J., Brown, J., Shafford, E., Perilongo, G., Brock, P., Dicks-Mireaux, C., . . . Plaschkes, J. (2000). Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol, 18(22), 3819-3828.
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors (SIOPCNSGCTII). (2011-). [pågående studie]. (NCT01424839). Hentet fra http://clinicaltrials.gov/show/NCT01424839
Puget, S., Garnett, M., Wray, A., Grill, J., Habrand, J. L., Bodaert, N., . . . Sainte-Rose, C. (2007). Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg, 106(1 Suppl), 3-12.
Pui, C. H. (2006). Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program, 142-146.
Pui, C. H., & Evans, W. E. (2006). Treatment of acute lymphoblastic leukemia. N Engl J Med, 354(2), 166-178.
Pui, C. H., Schrappe, M., Ribeiro, R. C., & Niemeyer, C. M. (2004). Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program, 118-145.
Radros, J., All-Eriksson, C., Pal, N., Holm, S., Seregard, S., Soderman, M., . . . Holmin, S. (2018). Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications. Acta ophthalmologica, 96(8), e1040-e1041. https://doi.org/10.1111/aos.13796
Ready, P. D. (2010). Leishmaniasis emergence in Europe. Euro Surveill, 15(10), 19505.
Reddy, A. T., & Packer, R. J. (1999). Chemotherapy for low-grade gliomas. Childs Nerv Syst, 15(10), 506-513.
Reilly, A., Kersun, L. S., McDonald, K., Weinberg, A., Jawad, A. F., & Sullivan, K. E. (2010). The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol, 32(5), e177-181. https://doi.org/10.1097/MPH.0b013e3181d869f3
Reinfjell, T., Diseth, T., & Vikan, A. (2007). Barn og kreft: Barns tilpasning til og forståelse av alvorlig sykdom. Tidsskrift for Norsk Psykologforening, 44(6), 724-734.
Reiter, A. (2007). Diagnosis and treatment of childhood non-hodgkin lymphoma. Hematology Am Soc Hematol Educ Program, 285-296.
Reni, M., Gatta, G., Mazza, E., & Vecht, C. (2007). Ependymoma. Crit Rev Oncol Hematol, 63(1), 81-89.
Retningslinjer for smertelindring. (2009). Oslo: Den norske legeforening. Hentet fra https://www.legeforeningen.no/om-oss/publikasjoner/retningslinjer/retningslinjer-for-smertelindring-2009/
Richardson, E. A., Ho, B., & Huang, A. (2018). Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies. Journal of Korean Neurosurgical Society, 61(3), 302-311. https://doi.org/10.3340/jkns.2018.0061
Robinson, G. W., Orr, B. A., & Gajjar, A. (2014). Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer, 14, 258. https://doi.org/10.1186/1471-2407-14-258
Rosengren, B., Monge, O. R., & Flage, T. (1989). Proposal of a new pretreatment clinical TNM-classification of retinoblastoma. Acta Oncol, 28(4), 547-548.
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., . . . Kang, I. (2014). 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 58(3), e44-100. https://doi.org/10.1093/cid/cit684
Rutkowski, S. (2006). Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother, 6(8), 1211-1221.
Rutkowski, S., Bode, U., Deinlein, F., Ottensmeier, H., Warmuth-Metz, M., Soerensen, N., . . . Kuehl, J. (2005). Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med, 352(10), 978-986.
Rutter's child and adolescent psychiatry. (2008). (5 utg.). Oxford: Blackwell Publ.
Rønning, C., Sundet, K., Due-Tønnessen, B., Lundar, T., & Helseth, E. (2005). Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatr Neurosurg, 41(1), 15-21.
Saghafian-Hedengren, S., Soderstrom, I., Sverremark-Ekstrom, E., & Nilsson, A. (2018). Insights into defective serological memory after acute lymphoblastic leukaemia treatment: The role of the plasma cell survival niche, memory B-cells and gut microbiota in vaccine responses. Blood reviews, 32(1), 71-80. https://doi.org/10.1016/j.blre.2017.08.009
Sandven-Thrane, S. (2012). Leukokori er retinoblastom til det motsatte er bevist. Tidsskr Nor Laegeforen, 132(18), 2042. https://doi.org/10.4045/tidsskr.12.0931
Schellong, G., Dorffel, W., Claviez, A., Korholz, D., Mann, G., Scheel-Walter, H. G., . . . Ruhl, U. (2005). Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. J Clin Oncol, 23(25), 6181-6189.
Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Soderhall, S., & Taskinen, M. (2010). Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia, 24(2), 345-354.
Schrauder, A., Henke-Gendo, C., Seidemann, K., Sasse, M., Cario, G., Moericke, A., . . . Wessel, A. (2007). Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet, 369(9568), 1232. https://doi.org/10.1016/s0140-6736(07)60567-4
Schrey, D., Carceller Lechon, F., Malietzis, G., Moreno, L., Dufour, C., Chi, S., . . . Zacharoulis, S. (2016). Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature. J Neurooncol, 126(1), 81-90. https://doi.org/10.1007/s11060-015-1904-0
Schroeder, T. M., Chintagumpala, M., Okcu, M. F., Chiu, J. K., Teh, B. S., Woo, S. Y., & Paulino, A. C. (2008). Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys, 71(4), 987-993. https://doi.org/10.1016/j.ijrobp.2007.11.058
Schulz, H., Rehwald, U., Morschhauser, F., Elter, T., Driessen, C., Rudiger, T., . . . Reiser, M. (2008). Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood, 111(1), 109-111.
Shields, C. L., Mashayekhi, A., Cater, J., Shelil, A., Meadows, A. T., & Shields, J. A. (2004). Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. American journal of ophthalmology, 138(3), 329-337. https://doi.org/10.1016/j.ajo.2004.04.032
Shields, C. L., Meadows, A. T., Shields, J. A., Carvalho, C., & Smith, A. F. (2001). Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol, 119(9), 1269-1272.
Smedegaard, L. M., Poulsen, A., Kristensen, I. A., Rosthoj, S., Schmiegelow, K., & Nygaard, U. (2016). Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience. Pediatr Infect Dis J, 35(11), e348-e352. https://doi.org/10.1097/inf.0000000000001279
Smeland, S., Bielack, S. S., Whelan, J., Bernstein, M., Hogendoorn, P., Krailo, M. D., . . . Marina, N. (2019). Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer, 109, 36-50. https://doi.org/10.1016/j.ejca.2018.11.027
Sposto, R., Ertel, I. J., Jenkin, R. D., Boesel, C. P., Venes, J. L., Ortega, J. A., . . . Hammond, D. (1989). The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol, 7(2), 165-177. https://doi.org/10.1007/bf00165101
Spreafico, F., Pritchard Jones, K., Malogolowkin, M. H., Bergeron, C., Hale, J., de Kraker, J., . . . Graf, N. (2009). Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther, 9(12), 1807-1815. https://doi.org/10.1586/era.09.159
Stiller, C. (2007). Chilhood Cancer in Britain: incidence, survival, mortality. Oxford: Oxford University Press.
Stokland, T., Liu, J. F., Ironside, J. W., Ellison, D. W., Taylor, R., Robinson, K. J., . . . Walker, D. A. (2010). A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol, 12(12), 1257-1268.
Strauss, R., Neureiter, D., Westenburger, B., Wehler, M., Kirchner, T., & Hahn, E. G. (2004). Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients--a postmortem clinicopathologic analysis. Crit Care Med, 32(6), 1316-1321.
Sturm, D., Pfister, S. M., & Jones, D. T. W. (2017). Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management. J Clin Oncol, 35(21), 2370-2377. https://doi.org/10.1200/jco.2017.73.0242
Swanson, E. L., Amdur, R. J., Morris, C. G., Galloway, T. J., Marcus, R. B., Jr., Pincus, D. W., & Smith, A. (2011). Intracranial ependymomas treated with radiotherapy: long-term results from a single institution. J Neurooncol, 102(3), 451-457. https://doi.org/10.1007/s11060-010-0344-0
Syse, A. (2008). Does cancer affect marriage rates? Journal of cancer survivorship : research and practice, 2(3), 205-214. https://doi.org/10.1007/s11764-008-0062-1
Timmermann, B., Kortmann, R. D., Kuhl, J., Rutkowski, S., Meisner, C., Pietsch, T., . . . Bamberg, M. (2006). Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol, 24(10), 1554-1560.
Tsang, D. S., Murray, L., Ramaswamy, V., Zapotocky, M., Tabori, U., Bartels, U., . . . Laperriere, N. (2019). Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma. Neuro Oncol, 21(4), 547-557. https://doi.org/10.1093/neuonc/noy191
Tsang, D. S., Oliveira, C., Bouffet, E., Hawkins, C., Ramaswamy, V., Yee, R., . . . Laperriere, N. (2019). Repeat irradiation for children with supratentorial high-grade glioma. Pediatr Blood Cancer, 66(9), e27881. https://doi.org/10.1002/pbc.27881
Turaka, K., Shields, C. L., Meadows, A. T., & Leahey, A. (2012). Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer, 59(1), 121-125. https://doi.org/10.1002/pbc.23278
Van Dongen-Melman, J. E., Pruyn, J. F., De, G. A., Koot, H. M., Hahlen, K., & Verhulst, F. C. (1995). Late psychosocial consequences for parents of children who survived cancer. J Pediatr Psychol., 20(5), 567-586.
van Tilburg, C. M., van Gent, R., Bierings, M. B., Otto, S. A., Sanders, E. A., Nibbelke, E. E., . . . Tesselaar, K. (2011). Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up. Br J Haematol, 152(2), 201-210. https://doi.org/10.1111/j.1365-2141.2010.08478.x
Vanan, M. I., & Eisenstat, D. D. (2015). DIPG in Children - What Can We Learn from the Past? Frontiers in oncology, 5, 237. https://doi.org/10.3389/fonc.2015.00237
Wallace, W. H., Blacklay, A., Eiser, C., Davies, H., Hawkins, M., Levitt, G. A., & Jenney, M. E. (2001). Developing strategies for long term follow up of survivors of childhood cancer. BMJ, 323(7307), 271-274.
Wiegering, V., Frank, J., Freudenberg, S., Morbach, H., Schlegel, P. G., Eyrich, M., & Winkler, B. (2014). Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia. Leukemia & lymphoma, 55(4), 870-875. https://doi.org/10.3109/10428194.2013.816423
Wong, J. R., Morton, L. M., Tucker, M. A., Abramson, D. H., Seddon, J. M., Sampson, J. N., & Kleinerman, R. A. (2014). Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. J Clin Oncol, 32(29), 3284-3290. https://doi.org/10.1200/JCO.2013.54.7844
Wright, K. D., Green, D. M., & Daw, N. C. (2009). Late effects of treatment for wilms tumor. Pediatr Hematol Oncol, 26(6), 407-413.
Yousef, Y. A., Al-Hussaini, M., Mehyar, M., Sultan, I., Jaradat, I., AlRawashdeh, K., . . . Nawaiseh, I. (2015). PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES. Retina (Philadelphia, Pa.), 35(9), 1883-1889. https://doi.org/10.1097/iae.0000000000000547
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., . . . Sondel, P. M. (2010). Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med, 363(14), 1324-1334. https://doi.org/10.1056/NEJMoa0911123
Zacharoulis, S., Ashley, S., Moreno, L., Gentet, J. C., Massimino, M., & Frappaz, D. (2010). Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis. Childs Nerv Syst, 26(7), 905-911. https://doi.org/10.1007/s00381-009-1067-4
Zacharoulis, S., & Moreno, L. (2009). Ependymoma: an update. J Child Neurol, 24(11), 1431-1438.
Zeller, B., Gustafsson, G., Forestier, E., Abrahamsson, J., Clausen, N., Heldrup, J., . . . Hasle, H. (2005). Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol, 128(6), 797-804.
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., . . . Downing, J. R. (2015). Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med, 373(24), 2336-2346. https://doi.org/10.1056/NEJMoa1508054
Zsiros, J., Brugieres, L., Brock, P., Roebuck, D., Maibach, R., Zimmermann, A., . . . Perilongo, G. (2013). Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. The Lancet. Oncology, 14(9), 834-842. https://doi.org/10.1016/s1470-2045(13)70272-9
Aarsen, F. K., Van Dongen, H. R., Paquier, P. F., Van, M. M., & Catsman-Berrevoets, C. E. (2004). Long-term sequelae in children after cerebellar astrocytoma surgery. Neurology, 62(8), 1311-1316.